| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,318 |
5,667 |
$53K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
3,877 |
945 |
$38K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
4,317 |
1,116 |
$33K |
| 99223 |
Prolong inpt eval add15 m |
1,057 |
931 |
$33K |
| 99222 |
Initial hospital care, per day, moderate complexity |
1,026 |
911 |
$28K |
| 94729 |
|
1,936 |
1,810 |
$15K |
| 99233 |
Prolong inpt eval add15 m |
617 |
130 |
$13K |
| 94727 |
|
1,944 |
1,817 |
$13K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
646 |
578 |
$11K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,531 |
1,511 |
$8K |
| 94010 |
|
1,165 |
1,105 |
$6K |
| 99406 |
|
3,284 |
2,923 |
$5K |
| 94060 |
|
815 |
755 |
$5K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
96 |
85 |
$3K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
88 |
70 |
$666.00 |
| 90686 |
|
42 |
41 |
$217.27 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
329 |
273 |
$185.95 |
| 90688 |
|
92 |
79 |
$184.52 |
| G0008 |
Administration of influenza virus vaccine |
135 |
122 |
$136.77 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
32 |
32 |
$83.07 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,434 |
1,249 |
$59.17 |
| 94664 |
|
13 |
13 |
$14.68 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
4,706 |
4,080 |
$0.07 |
| 1124F |
|
8,708 |
7,740 |
$0.07 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
10,241 |
8,994 |
$0.07 |
| G9991 |
Patient received any pneumococcal conjugate or polysaccharide vaccine on or after their 19th birthday and before the end of the measurement period |
1,038 |
917 |
$0.04 |
| G8482 |
Influenza immunization administered or previously received |
5,290 |
4,714 |
$0.04 |
| G8484 |
Influenza immunization was not administered, reason not given |
1,968 |
1,810 |
$0.02 |
| 1036F |
|
2,266 |
2,055 |
$0.01 |
| 4040F |
|
3,468 |
3,096 |
$0.01 |
| 3023F |
|
1,163 |
1,087 |
$0.01 |
| G9906 |
Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) |
2,145 |
1,882 |
$0.00 |
| 1123F |
|
899 |
796 |
$0.00 |
| 3025F |
|
257 |
236 |
$0.00 |
| 4140F |
|
48 |
38 |
$0.00 |
| 4004F |
|
1,093 |
992 |
$0.00 |
| G9990 |
Patient did not receive any pneumococcal conjugate or polysaccharide vaccine on or after their 19th birthday and before the end of the measurement period |
138 |
118 |
$0.00 |
| 4025F |
|
255 |
237 |
$0.00 |
| G8483 |
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) |
259 |
224 |
$0.00 |